Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 87

1.

Treating Hyperthyroidism in the Critically Ill Patient with Rectal Methimazole.

Zamora JM, Joy G, Mattman A, Ur E.

Clin Endocrinol (Oxf). 2020 Jan 13. doi: 10.1111/cen.14159. [Epub ahead of print]

PMID:
31943250
2.

Diabetes Nurse Case Management in a Canadian Tertiary Care Setting: Results of a Randomized Controlled Trial.

Li D, Elliott T, Klein G, Ur E, Tang TS.

Can J Diabetes. 2017 Jun;41(3):297-304. doi: 10.1016/j.jcjd.2016.10.012. Epub 2017 Mar 18.

PMID:
28318938
3.

Angiographic evidence of proliferative retinopathy predicts neuropsychiatric morbidity in diabetic patients.

Serlin Y, Shafat T, Levy J, Winter A, Shneck M, Knyazer B, Parmet Y, Shalev H, Ur E, Friedman A.

Psychoneuroendocrinology. 2016 May;67:163-70. doi: 10.1016/j.psyneuen.2016.02.009. Epub 2016 Feb 12.

PMID:
26907995
4.

Preventing diabetes in primary care: a feasibility cluster randomized trial.

Dawes D, Ashe M, Campbell K, Cave D, Elley CR, Kaczorowski J, Sohal P, Ur E, Dawes M.

Can J Diabetes. 2015 Apr;39(2):111-6. doi: 10.1016/j.jcjd.2014.08.004. Epub 2014 Nov 21.

5.

Are the ACC/AHA guidelines on the treatment of blood cholesterol a game changer? A perspective from the Canadian Cardiovascular Society Dyslipidemia Panel.

Anderson TJ, Grégoire J, Hegele RA, Couture P, Mancini GB, McPherson R, Francis GA, Poirier P, Lau DC, Grover S, Genest J Jr, Carpentier AC, Dufour R, Gupta M, Ward R, Leiter LA, Lonn E, Ng DS, Pearson GJ, Yates GM, Stone JA, Ur E.

Can J Cardiol. 2014 Apr;30(4):377-80. doi: 10.1016/j.cjca.2014.01.009. Epub 2014 Jan 17. No abstract available.

PMID:
24589194
6.

Glucocorticoid-induced hyperglycemia is prevalent and unpredictable for patients undergoing cancer therapy: an observational cohort study.

Harris D, Barts A, Connors J, Dahl M, Elliott T, Kong J, Keane T, Thompson D, Stafford S, Ur E, Sirrs S.

Curr Oncol. 2013 Dec;20(6):e532-8. doi: 10.3747/co.20.1499.

7.

Inflammatory biomarkers CRP, MCP-1, serum amyloid alpha and interleukin-18 in patients with HTN and dyslipidemia: impact of diabetes mellitus on metabolic syndrome and the effect of statin therapy.

Rabkin SW, Langer A, Ur E, Calciu CD, Leiter LA.

Hypertens Res. 2013 Jun;36(6):550-8. doi: 10.1038/hr.2012.214. Epub 2013 Feb 7.

PMID:
23388885
8.

2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult.

Anderson TJ, Grégoire J, Hegele RA, Couture P, Mancini GB, McPherson R, Francis GA, Poirier P, Lau DC, Grover S, Genest J Jr, Carpentier AC, Dufour R, Gupta M, Ward R, Leiter LA, Lonn E, Ng DS, Pearson GJ, Yates GM, Stone JA, Ur E.

Can J Cardiol. 2013 Feb;29(2):151-67. doi: 10.1016/j.cjca.2012.11.032. Review.

PMID:
23351925
9.

Emerging trends in the diagnosis and treatment of acromegaly in Canada.

Vallette S, Ezzat S, Chik C, Ur E, Imran SA, Van Uum S, Rivera J, Caspar-Bell G, Serri O.

Clin Endocrinol (Oxf). 2013 Jul;79(1):79-85. doi: 10.1111/cen.12112. Epub 2013 Apr 27.

PMID:
23190441
10.

COST: Cognitive State Test, a brief screening battery for Alzheimer disease in illiterate and literate patients.

Babacan-Yildiz G, Isik AT, Ur E, Aydemir E, Ertas C, Cebi M, Soysal P, Gursoy E, Kolukisa M, Kocaman G, Celebi A.

Int Psychogeriatr. 2013 Mar;25(3):403-12. doi: 10.1017/S1041610212001780. Epub 2012 Nov 9.

PMID:
23137551
11.

Management of prolactinomas during pregnancy -- a survey of four Canadian provinces.

Almalki MH, Ur E, Johnson M, Clarke DB, Imran SA.

Clin Invest Med. 2012 Apr 1;35(2):E96-104.

PMID:
22469109
12.

Poor achievement of guidelines-recommended targets in type 2 diabetes: findings from a contemporary prospective cohort study.

Braga MF, Casanova A, Teoh H, Gerstein HC, Fitchett DH, Honos G, McFarlane PA, Ur E, Yale JF, Langer A, Goodman SG, Leiter LA; Diabetes Registry to Improve Vascular Events [DRIVE] Investigators.

Int J Clin Pract. 2012 May;66(5):457-64. doi: 10.1111/j.1742-1241.2012.02894.x. Epub 2012 Mar 27.

PMID:
22452524
13.

Characterization of management and outcomes of patients with acromegaly in Vancouver over 30 years.

Almalki MH, Chesover AD, Johnson MD, Wilkins GE, Maguire JA, Ur E.

Clin Invest Med. 2012 Feb 1;35(1):E27-33.

PMID:
22309962
14.

Cost-effectiveness of second-line antihyperglycemic therapy in patients with type 2 diabetes mellitus inadequately controlled on metformin.

Klarenbach S, Cameron C, Singh S, Ur E.

CMAJ. 2011 Nov 8;183(16):E1213-20. doi: 10.1503/cmaj.110178. Epub 2011 Oct 3.

15.

Identification and management of cardiometabolic risk in Canada: a position paper by the cardiometabolic risk working group (executive summary).

Cardiometabolic Risk Working Group: Executive Committee, Leiter LA, Fitchett DH, Gilbert RE, Gupta M, Mancini GB, McFarlane PA, Ross R, Teoh H, Verma S, Anand S, Camelon K, Chow CM, Cox JL, Després JP, Genest J, Harris SB, Lau DC, Lewanczuk R, Liu PP, Lonn EM, McPherson R, Poirier P, Qaadri S, Rabasa-Lhoret R, Rabkin SW, Sharma AM, Steele AW, Stone JA, Tardif JC, Tobe S, Ur E.

Can J Cardiol. 2011 Mar-Apr;27(2):124-31. doi: 10.1016/j.cjca.2011.01.016. Review.

PMID:
21459258
16.

Cardiometabolic risk in Canada: a detailed analysis and position paper by the cardiometabolic risk working group.

Cardiometabolic Risk Working Group: Executive Committee, Leiter LA, Fitchett DH, Gilbert RE, Gupta M, Mancini GB, McFarlane PA, Ross R, Teoh H, Verma S, Anand S, Camelon K, Chow CM, Cox JL, Després JP, Genest J, Harris SB, Lau DC, Lewanczuk R, Liu PP, Lonn EM, McPherson R, Poirier P, Qaadri S, Rabasa-Lhoret R, Rabkin SW, Sharma AM, Steele AW, Stone JA, Tardif JC, Tobe S, Ur E.

Can J Cardiol. 2011 Mar-Apr;27(2):e1-e33. doi: 10.1016/j.cjca.2010.12.054. Review.

PMID:
21459257
17.

Comment on: Kim et al. (2010) Hypothalamic Angptl4/Fiaf is a novel regulator of food intake and body weight. Diabetes;59:2772-2780.

Wilkinson M, Brown RE, Imran SA, Ur E.

Diabetes. 2011 Jan;60(1):e1; author reply e2. doi: 10.2337/db10-1348. No abstract available.

18.

Patient age, ethnicity, medical history, and risk factor profile, but not drug insurance coverage, predict successful attainment of glycemic targets: Time 2 Do More Quality Enhancement Research Initiative (T2DM QUERI).

Teoh H, Braga MF, Casanova A, Drouin D, Goodman SG, Harris SB, Langer A, Tan MK, Ur E, Yan AT, Zinman B, Leiter LA; T2DM QUERI Investigators.

Diabetes Care. 2010 Dec;33(12):2558-60. doi: 10.2337/dc10-0440. Epub 2010 Sep 7.

19.

Treatment gaps in the management of cardiovascular risk factors in patients with type 2 diabetes in Canada.

Braga M, Casanova A, Teoh H, Dawson KC, Gerstein HC, Fitchett DH, Harris SB, Honos G, McFarlane PA, Steele A, Ur E, Yale JF, Langer A, Goodman SG, Leiter LA; Diabetes Registry to Improve Vascular Events (DRIVE) Investigators.

Can J Cardiol. 2010 Jun-Jul;26(6):297-302.

20.

Impact of admission serum glucose level on in-hospital outcomes following coronary artery bypass grafting surgery.

Imran SA, Ransom TP, Buth KJ, Clayton D, Al-Shehri B, Ur E, Ali IS.

Can J Cardiol. 2010 Mar;26(3):151-4.

21.

Frontal assessment battery in patients with Parkinson disease in a Turkish population.

Kenangil G, Orken DN, Ur E, Forta H.

Cogn Behav Neurol. 2010 Mar;23(1):26-8. doi: 10.1097/WNN.0b013e3181c5e2b0.

PMID:
20299860
23.

Cost-effectiveness of self-monitoring of blood glucose in patients with type 2 diabetes mellitus managed without insulin.

Cameron C, Coyle D, Ur E, Klarenbach S.

CMAJ. 2010 Jan 12;182(1):28-34. doi: 10.1503/cmaj.090765. Epub 2009 Dec 21.

24.

A Canadian multi-centre, open-label long-term study of Pegvisomant treatment in refractory acromegaly.

Ezzat S, Gaspo R, Serri O, Ur E, Chik CL.

Clin Invest Med. 2009 Dec 1;32(6):E265.

PMID:
20003832
25.

2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult - 2009 recommendations.

Genest J, McPherson R, Frohlich J, Anderson T, Campbell N, Carpentier A, Couture P, Dufour R, Fodor G, Francis GA, Grover S, Gupta M, Hegele RA, Lau DC, Leiter L, Lewis GF, Lonn E, Mancini GB, Ng D, Pearson GJ, Sniderman A, Stone JA, Ur E.

Can J Cardiol. 2009 Oct;25(10):567-79. Review.

26.

Outcome of stereotactic radiotherapy for patients with uncontrolled acromegaly.

Imran SA, Fleetwood IG, O'Connell CM, Ransom TP, Mulroy LA, Ur E, Clarke DB.

Can J Neurol Sci. 2009 Jul;36(4):468-74.

PMID:
19650358
27.

The relation of testosterone levels with fatigue and apathy in Parkinson's disease.

Kenangil G, Orken DN, Ur E, Forta H, Celik M.

Clin Neurol Neurosurg. 2009 Jun;111(5):412-4. doi: 10.1016/j.clineuro.2008.11.019. Epub 2009 Jan 8.

PMID:
19131155
28.

Atypical ketosis-prone diabetes.

Imran SA, Ur E.

Can Fam Physician. 2008 Nov;54(11):1553-4. No abstract available.

29.

Valproic acid and CEBPalpha-mediated regulation of adipokine gene expression in hypothalamic neurons and 3T3-L1 adipocytes.

Brown R, Imran SA, Ur E, Wilkinson M.

Neuroendocrinology. 2008;88(1):25-34. doi: 10.1159/000113927. Epub 2008 Jan 22.

PMID:
18212493
30.

Traumatic brain injury induces adipokine gene expression in rat brain.

Brown R, Thompson HJ, Imran SA, Ur E, Wilkinson M.

Neurosci Lett. 2008 Feb 13;432(1):73-8. doi: 10.1016/j.neulet.2007.12.008. Epub 2007 Dec 15.

31.

KiSS-1 mRNA in adipose tissue is regulated by sex hormones and food intake.

Brown RE, Imran SA, Ur E, Wilkinson M.

Mol Cell Endocrinol. 2008 Jan 16;281(1-2):64-72. Epub 2007 Nov 1.

PMID:
18069123
32.

Adipokine gene expression in brain and pituitary gland.

Wilkinson M, Brown R, Imran SA, Ur E.

Neuroendocrinology. 2007;86(3):191-209. Epub 2007 Sep 19. Review.

PMID:
17878708
33.

Managing prolactin-secreting adenomas during pregnancy.

Imran SA, Ur E, Clarke DB.

Can Fam Physician. 2007 Apr;53(4):653-8. Review.

34.

Adipokine gene expression in a novel hypothalamic neuronal cell line: resistin-dependent regulation of fasting-induced adipose factor and SOCS-3.

Brown R, Imran SA, Belsham DD, Ur E, Wilkinson M.

Neuroendocrinology. 2007;85(4):232-41. Epub 2007 Jun 19.

PMID:
17579277
35.

2006 Canadian clinical practice guidelines on the management and prevention of obesity in adults and children [summary].

Lau DC, Douketis JD, Morrison KM, Hramiak IM, Sharma AM, Ur E; Obesity Canada Clinical Practice Guidelines Expert Panel.

CMAJ. 2007 Apr 10;176(8):S1-13. Review. No abstract available.

36.

A frameshift mutation in peroxisome-proliferator-activated receptor-gamma in familial partial lipodystrophy subtype 3 (FPLD3; MIM 604367).

Hegele RA, Ur E, Ransom TP, Cao H.

Clin Genet. 2006 Oct;70(4):360-2. No abstract available.

PMID:
16965332
37.

Folic acid improves endothelial dysfunction in type 2 diabetes--an effect independent of homocysteine-lowering.

Title LM, Ur E, Giddens K, McQueen MJ, Nassar BA.

Vasc Med. 2006 May;11(2):101-9.

PMID:
16886840
38.

Increased expression of the adipokine genes resistin and fasting-induced adipose factor in hypoxic/ischaemic mouse brain.

Wiesner G, Brown RE, Robertson GS, Imran SA, Ur E, Wilkinson M.

Neuroreport. 2006 Jul 31;17(11):1195-8.

PMID:
16837853
39.

The obesity epidemic and its cardiovascular consequences.

Behn A, Ur E.

Curr Opin Cardiol. 2006 Jul;21(4):353-60. Review.

PMID:
16755205
40.

Canadian guidelines for the management of adult growth hormone deficiency.

Ur E, Serri O, Legg K, Murphy LJ, Ezzat S.

Clin Invest Med. 2006 Apr;29(2):83-90.

PMID:
16737084
41.

Anemia is an independent risk for mortality after acute myocardial infarction in patients with and without diabetes.

Shu DH, Ransom TP, O'Connell CM, Cox JL, Kaiser SM, Gee SA, Rowe RC, Ur E, Imran SA.

Cardiovasc Diabetol. 2006 Apr 7;5:8.

42.

Canadian consensus guidelines for the diagnosis and management of acromegaly.

Ezzat S, Serri O, Chik CL, Johnson MD, Beauregard H, Marcovitz S, Nyomba BL, Ramirez JR, Ur E.

Clin Invest Med. 2006 Feb;29(1):29-39.

PMID:
16553361
43.

RNAi-mediated silencing of leptin gene expression increases cell death in C6 glioblastoma cells.

Brown R, Morash B, Ur E, Wilkinson M.

Brain Res Mol Brain Res. 2005 Oct 3;139(2):357-60.

PMID:
15964097
44.

Pituitary resistin gene expression is upregulated in vitro and in vivo by dexamethasone but is unaffected by rosiglitazone.

Brown R, Wiesner G, Ur E, Wilkinson M.

Neuroendocrinology. 2005;81(1):41-8. Epub 2005 Apr 1.

PMID:
15809511
45.

Hypothalamic resistin immunoreactivity is reduced by obesity in the mouse: co-localization with alpha-melanostimulating hormone.

Wilkinson M, Wilkinson D, Wiesner G, Morash B, Ur E.

Neuroendocrinology. 2005;81(1):19-30. Epub 2005 Apr 1.

PMID:
15809509
46.

An overview of the role of insulin in the treatment of hyperglycemia during acute myocardial ischemia.

Imran SA, Malmberg K, Cox JL, Ransom TP, Ur E.

Can J Cardiol. 2004 Nov;20(13):1361-5. Review.

PMID:
15565201
47.

Pituitary resistin gene expression: effects of age, gender and obesity.

Morash BA, Ur E, Wiesner G, Roy J, Wilkinson M.

Neuroendocrinology. 2004 Mar;79(3):149-56. Epub 2004 Apr 16.

PMID:
15103228
48.

Food restriction regulates adipose-specific cytokines in pituitary gland but not in hypothalamus.

Wiesner G, Morash BA, Ur E, Wilkinson M.

J Endocrinol. 2004 Mar;180(3):R1-6.

PMID:
15012606
49.
50.

Leptin receptors are developmentally regulated in rat pituitary and hypothalamus.

Morash BA, Imran A, Wilkinson D, Ur E, Wilkinson M.

Mol Cell Endocrinol. 2003 Nov 28;210(1-2):1-8.

PMID:
14615055

Supplemental Content

Support Center